Therapie neuropathischer Schmerzen

Lernziele

Die klinischen Charakteristika von neuropathischen Schmerzen beschreiben können Die Grundzüge der Diagnostik bei neuropathischen Schmerzen kennen Die wichtigsten Stoffgruppen in der medikamentösen Behandlung von neuropathischen Schmerzen kennen und differenziert einsetzen können Über die Notwendigkeit der individuellen Erprobung der Medikamente unter Berücksichtigung von Nebenwirkungen und Kontraindikationen informiert sein Grundkenntnisse zu neueren Entwicklungen in der Pharmakotherapie neuropathischer Schmerzen erwerben

Literatur

• 1 Baron R. Neuropathische Schmerzen. Der lange Weg vom Mechanismus zur mechanismenorientierten Therapie.  Anaesthesist. 2000;  49 373-386
• 2 Hansson P. Difficulties in stratifying neuropathic pain by mechanisms.  Eur J Pain. 2003;  7 353-357
• 3 Sommer C. Therapie neuropathischer Schmerzsyndrome. Bremen; Unimed-Verlag 2006
• 4 Birklein F. Complex regional pain syndrome.  J Neurol. 2005;  252 131-138
• 5 Fields H L, Rowbotham M, Baron R. Postherpetic neuralgia: irritable nociceptors and deafferentation.  Neurobiol Dis. 1998;  5 209-227
• 6 Bouhassira D, Attal N, Fermanian J. et al . Development and validation of the Neuropathic Pain Symptom Inventory.  Pain. 2004;  108 248-257
• 7 Geis C, Feierabend S, Böhner W. et al . Schemata zur Schmerzeinzeichnung bei Patienten mit orofazialen Schmerzen: Vergleich von Akzeptanz und Informationsgehalt.  Schmerz. 2006;  20 498-508
• 8 Attal N, Cruccu G, Haanpaa M. et al . EFNS guidelines on pharmacological treatment of neuropathic pain.  Eur J Neurol. 2006;  13 1153-1169
• 9 Rolke R, Baron R, Maier C. et al . Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): standardized protocol and reference values.  Pain. 2006;  123 231-243
• 10 Lauria G, Cornblath D R, Johansson O. et al . EFNS guidelines on the use of skin biopsy in the diagnosis of peripheral neuropathy.  Eur J Neurol. 2005;  12 747-758
• 11 Hoitsma E, Marziniak M, Faber C G. et al . Small fibre neuropathy in sarcoidosis.  Lancet. 2002;  359 2085-2086
• 12 Sommer C. Painful neuropathies.  Curr Opin Neurol. 2003;  16 623-628
• 13 Woolf C J. Dissecting out mechanisms responsible for peripheral neuropathic pain: implications for diagnosis and therapy.  Life Sci. 2004;  74 2605-2610
• 14 Campbell J N, Meyer R A. Mechanisms of neuropathic pain.  Neuron. 2006;  52 77-92
• 15 Leis S, Weber M, Schmelz M, Birklein F. Facilitated neurogenic inflammation in unaffected limbs of patients with complex regional pain syndrome.  Neurosci Lett. 2004;  359 163-166
• 16 Devor M. Sodium channels and mechanisms of neuropathic pain.  J Pain. 2006;  7 S3-S12
• 17 Üceyler N, Sommer C. Wallerian degeneration and neuropathic pain.  Drug Discovery Today: Disease Mechanisms. 2006;  3 351-356
• 18 Moalem G, Tracey D J. Immune and inflammatory mechanisms in neuropathic pain.  Brain research. 2006;  51 240-264
• 19 Suzuki R, Dickenson A. Spinal and supraspinal contributions to central sensitization in peripheral neuropathy.  Neurosignals. 2005;  14 175-181
• 20 Baron R, Sommer C, Tölle T R. et al . Diagnostik und Therapie neuropathischer Schmerzen. In: Diener HC, Putzki N, Berlit P (Hrsg) Leitlinien für Diagnostik und Therapie in der Neurologie. 3. Aufl. Stuttgart; Thieme 2005
• 21 Sommer C (Hrsg). Therapie neuropathischer Schmerzsyndrome. 2. Aufl. Bremen; Unimed-Verlag 2006
• 22 Carroll D, Moore R A, McQuay H J. et al .Transcutaneous electrical nerve stimulation (TENS) for chronic pain. Cochrane Database Syst Rev 2001 CD003222
• 23 Taylor R S. Spinal cord stimulation in complex regional pain syndrome and refractory neuropathic back and leg pain/failed back surgery syndrome: results of a systematic review and meta-analysis.  Journal of pain and symptom management. 2006;  31 S13-19
• 24 Galer B S, Rowbotham M C, Perander J, Friedman E. Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study.  Pain. 1999;  80 533-538
• 25 Meier T, Wasner G, Faust M. et al . Efficacy of lidocaine patch 5 % in the treatment of focal peripheral neuropathic pain syndromes: a randomized, double-blind, placebo-controlled study.  Pain. 2003;  106 151-158
• 26 Saarto T, Wiffen P J. Antidepressants for neuropathic pain. Cochrane Database Syst Rev 2005 CD005454
• 27 Wernicke J F, Pritchett Y L, D'Souza D N. et al . A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain.  Neurology. 2006;  67 1411-1420
• 28 Raskin J, Pritchett Y L, Wang F. et al . A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain.  Pain Med. 2005;  6 346-356
• 29 Goldstein D J, Lu Y, Detke M J. et al . Duloxetine vs. placebo in patients with painful diabetic neuropathy.  Pain. 2005;  116 109-118
• 30 Wiffen P J, McQuay H J, Edwards J E, Moore R A. Gabapentin for acute and chronic pain. Cochrane Database Syst Rev 2005 CD005452
• 31 Rosenstock J, Tuchman M, LaMoreaux L, Sharma U. Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial.  Pain. 2004;  110 628-638
• 32 Dworkin R H, Corbin A E, Young Jr J P. et al . Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial.  Neurology. 2003;  60 1274-1283
• 33 Dogra S, Beydoun S, Mazzola J. et al . Oxcarbazepine in painful diabetic neuropathy: a randomized, placebo-controlled study.  Eur J Pain. 2005;  9 543-554
• 34 Grosskopf J, Mazzola J, Wan Y, Hopwood M. A randomized, placebo-controlled study of oxcarbazepine in painful diabetic neuropathy.  Acta Neurol Scand. 2006;  114 177-180
• 35 Eisenberg E, Lurie Y, Braker C. et al . Lamotrigine reduces painful diabetic neuropathy: A randomized, controlled study.  Neurology. 2001;  57 505-509
• 36 Simpson D M, McArthur J C, Olney R. et al . Lamotrigine for HIV-associated painful sensory neuropathies: a placebo-controlled trial.  Neurology. 2003;  60 1508-1514
• 37 Hollingshead J, Duhmke R M, Cornblath D R. Tramadol for neuropathic pain. Cochrane Database Syst Rev 2006 3 CD003726
• 38 Watson C P. The treatment of neuropathic pain: antidepressants and opioids.  Clin J Pain. 2000;  16 S49-55
• 39 Hojsted J, Sjogren P. Addiction to opioids in chronic pain patients: A literature review.  Eur J Pain. ePub 2006; 
• 40 Moore R A, McQuay H J. Prevalence of opioid adverse events in chronic non-malignant pain: systematic review of randomised trials of oral opioids.  Arthritis Res Ther. 2005;  7 R1046-1051
• 41 Abram S E. Neural blockade for neuropathic pain.  Clin J Pain. 2000;  16 S56-61
• 42 Vroomen P C, Krom M C de, Slofstra P D, Knottnerus J A. Conservative treatment of sciatica: a systematic review.  J Spinal Disord. 2000;  13 463-469
• 43 Karppinen J, Malmivaara A, Kurunlahti M. et al . Periradicular infiltration for sciatica: a randomized controlled trial.  Spine. 2001;  26 1059-1067
• 44 Christensen K, Jensen E M, Noer I. The reflex dystrophy syndrome response to treatment with systemic corticosteroids.  Acta Chir Scand. 1982;  148 653-655
• 45 Üceyler N, Rogausch J, Toyka K, Sommer C. Differential expression of cytokines in painful and painless neuropathies.  Neurology. 2007;  69 42-49
• 46 Gilron I, Bailey J M, Tu D. et al . Morphine, gabapentin, or their combination for neuropathic pain.  N Engl J Med. 2005;  352 1324-1334
• 47 Rauck R L, Shaibani A, Biton V. et al . Lacosamide in painful diabetic peripheral neuropathy: a phase 2 double-blind placebo-controlled study.  Clin J Pain. 2007;  23 150-158
• 48 Rowbotham M C, Manville N S, Ren J. Pilot tolerability and effectiveness study of levetiracetam for postherpetic neuralgia.  Neurology. 2003;  61 866-867
• 49 Rice A S, Hill R G. New treatments for neuropathic pain.  Annu Rev Med. 2006;  57 535-551